Skip to main content

Liver Diseases

The Liver Diseases group is a referent at the local, national and international level in research, and is one of the most active groups in clinical research at VHIR. The group's prominent involvement in clinical trials is a clear indication of our professionals' commitment to ensuring that patients have access to state-of-the-art therapies. Our participation and collaboration in international projects and consortiums are also a fundamental characteristic of the group. The main objective of the group is to become one of the best translational research groups in liver diseases. It is essential to be able to apply all the findings of basic research to clinical research to improve the health of patients with liver disease.

Team

David Tabernero Caellas

David Tabernero Caellas

Senior researcher
Liver Diseases
Read more
Emma Bigas Alsina

Emma Bigas Alsina

Research technician
Liver Diseases
Read more
Ester Palacio Gutierrez

Ester Palacio Gutierrez

Research technician
Liver Diseases
Read more
Heba Gadelkareem

Heba Gadelkareem

Research assistant
Liver Diseases
Read more
Immaculada Raurell Saborit

Immaculada Raurell Saborit

Postdoctoral researcher
Liver Diseases
Read more
Isabel Campos Varela

Isabel Campos Varela

Main researcher
Liver Diseases
Read more
David Tabernero Caellas

David Tabernero Caellas

Senior researcher
Liver Diseases
Read more
Emma Bigas Alsina

Emma Bigas Alsina

Research technician
Liver Diseases
Read more
Ester Palacio Gutierrez

Ester Palacio Gutierrez

Research technician
Liver Diseases
Read more
Heba Gadelkareem

Heba Gadelkareem

Research assistant
Liver Diseases
Read more
Immaculada Raurell Saborit

Immaculada Raurell Saborit

Postdoctoral researcher
Liver Diseases
Read more
Isabel Campos Varela

Isabel Campos Varela

Main researcher
Liver Diseases
Read more

Projects

pendent

IP: Joan Genescà Ferrer
Collaborators: Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR21/00064
Duration: 01/01/2022 - 31/12/2025

Seniority no ERC

IP: Josep Quer Sivila
Collaborators: -
Funding agency: VHIR
Funding: 225000
Reference: VHIR/SENIORITY_NO_ERC/21/QUER
Duration: 01/05/2021 - 30/04/2026

LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

IP: Victor Manuel Vargas Blasco
Collaborators: Ester Palacio Gutierrez, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer, Cesar Jimenez Hernandez
Funding agency: EUROPEAN COMMISSION
Funding: 409557
Reference: LIVERHOPE_H2020RTD2016
Duration: 01/01/2017 - 28/02/2023

De la sencillez en el diagnóstico (no masivo) y seguimiento de la enfermedad hepática crónica avanzada a los complejos mecanismos terapéuticos de las estatinas en modelos animales.

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Torrens Buscató, Maria Margarita, Ares Aurora Villagrasa Vilella, Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI18/00947
Duration: 01/01/2019 - 30/06/2023

Publications

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers.

PMID: 37745192
Journal: JHEP Reports
Year: 2023
Reference: JHEP Rep. 2023 Jul 13;5(10):100842. doi: 10.1016/j.jhepr.2023.100842. eCollection 2023 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Berg, Thomas; Bes, Marta; Buti, Maria; Buti, Maria; Casillas, Rosario; Esteban, Rafael; Esteban, Rafael; Palom, Adriana; Pfefferkorn, Maria; Rando-Segura, Ariadna et al.
DOI: 10.1016/j.jhepr.2023.100842

HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY.

PMID: 37769952
Journal: Gastroenterology
Year: 2023
Reference: Gastroenterology. 2023 Sep 26:S0016-5085(23)05068-0. doi: 10.1053/j.gastro.2023.09.033.
Impact factor:
Publication type: Paper in international publication
Authors: Agarwal, K; Ahn, S H; Berg, T; Boonstra, A; Brakenhoff, S M; Brunetto, M; Buti, M; Buti, M; Carey, I; Chen, C-H et al.
DOI: 10.1053/j.gastro.2023.09.033

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

PMID: 37771546
Journal: JHEP Reports
Year: 2023
Reference: JHEP Rep. 2023 Jul 13;5(10):100847. doi: 10.1016/j.jhepr.2023.100847. eCollection 2023 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Abramov, Frida; Agarwal, Kosh; Ahn, Sang Hoon; Brunetto, Maurizia; Buti, Maria; Buti, Maria; Chan, Henry L Y; Chang, Ting-Tsung; Chuang, Wan Long; Flaherty, John F et al.
DOI: 10.1016/j.jhepr.2023.100847

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola.

PMID: 37789462
Journal: Parasites & Vectors
Year: 2023
Reference: Parasit Vectors. 2023 Oct 3;16(1):343. doi: 10.1186/s13071-023-05942-7.
Impact factor:
Publication type: Paper in international publication
Authors: Aixut, Sandra; Crego-Vicente, Beatriz; Febrer-Sendra, Begona; Fernandez-Soto, Pedro; Martinez-Camprecios, Joan; Martinez-Camprecios, Joan; Mediavilla, Alejandro; Molina, Israel; Molina, Israel; Muro, Antonio et al.
DOI: 10.1186/s13071-023-05942-7

Sweet's syndrome and Crohn's disease diagnosed simultaneously.

PMID: 35658996
Journal: LANCET
Year: 2022
Reference: Lancet. 2022 Jun 4;399(10341):2155. doi: 10.1016/S0140-6736(22)00915-1.
Impact factor: 79.323
Publication type: Letter or abstract
Authors: Banares, Juan, Aceituno, Laia, Jimenez, Alba, Maynard, Avonello, Escobar, Eduardo Dacosta, Aleman, Carmen et al.
DOI: 10.1016/S0140-6736(22)00915-1

Prevalence estimation of significant fibrosis due to NASH in Spain combining transient elastography and histology.

PMID: 35643936
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 May 28. doi: 10.1111/liv.15323.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Calleja, Jose Luis, Rivera-Esteban, Jesus, Aller, Rocio, Hernandez Conde, Marta, Abad, Javier, Pericas, Juan M, Serra, Miguel Angel, Escudero, Amparo, Ampuero, Javier, Lucena, Ana et al.
DOI: 10.1111/liv.15323

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 May 30. doi: 10.1111/liv.15327.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Martro, Elisa, Ouaarab, Hakima, Saludes, Veronica, Buti, Maria, Trevino, Begona, Roade, Luisa, Egea-Cortes, Laia, Reyes-Urena, Juliana, Not, Anna, Majo, Xavier et al.
DOI: 10.1111/liv.15327

Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis.

PMID: 35625751
Journal: Biomedicines
Year: 2022
Reference: Biomedicines. 2022 Apr 28;10(5). pii: biomedicines10051015. doi: 10.3390/biomedicines10051015.
Impact factor: 6.081
Publication type: Paper in international publication
Authors: Gabriel-Medina, Pablo, Ferrer-Costa, Roser, Rodriguez-Frias, Francisco, Ciudin, Andreea, Augustin, Salvador, Rivera-Esteban, Jesus, Pericas, Juan M, Selva, David Martinez et al.
DOI: 10.3390/biomedicines10051015

Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH.

PMID: 34014280
Journal: Disease Models & Mechanisms
Year: 2021
Reference: Dis Model Mech. 2021 May 1;14(5). pii: 268318. doi: 10.1242/dmm.048884. Epub 2021 May 20.
Impact factor: 5.758
Publication type: Paper in international publication
Authors: Bravo, Miren, Raurell, Imma, Barbera, Aurora, Hide, Diana, Gil, Mar, Estrella, Federico, Salcedo, Maria Teresa, Augustin, Salvador, Genesca, Joan, Martell, Maria et al.
DOI: 10.1242/dmm.048884

Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects.

PMID: 33880971
Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Year: 2021
Reference: Expert Rev Mol Diagn. 2021 Apr;21(4):381-396. doi: 10.1080/14737159.2021.1913055. Epub 2021 Apr 21.
Impact factor: 5.225
Publication type: Review in international publication
Authors: Garcia-Garcia, Selene, Cortese, Maria Francesca, Rodriguez-Algarra, Francisco, Tabernero, David, Rando-Segura, Ariadna, Quer, Josep, Buti, Maria, Rodriguez-Frias, Francisco et al.
DOI: 10.1080/14737159.2021.1913055

Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.

PMID: 33278456
Journal: JOURNAL OF HEPATOLOGY
Year: 2021
Reference: J Hepatol. 2021 May;74(5):1064-1074. doi: 10.1016/j.jhep.2020.11.043. Epub 2020 Dec 2.
Impact factor: 25.083
Publication type: Paper in international publication
Authors: Garcia-Lopez, Mireia, Lens, Sabela, Pallett, Laura J, Testoni, Barbara, Rodriguez-Tajes, Sergio, Marino, Zoe, Bartres, Concepcion, Garcia-Pras, Ester, Leonel, Thais, Perpinan, Elena et al.
DOI: 10.1016/j.jhep.2020.11.043

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.

PMID: 33227350
Journal: JOURNAL OF HEPATOLOGY
Year: 2021
Reference: J Hepatol. 2021 May;74(5):1097-1108. doi: 10.1016/j.jhep.2020.11.019. Epub 2020 Nov 20.
Impact factor: 25.083
Publication type: Paper in international publication
Authors: Francoz, Claire, Piano, Salvatore, Berg, Thomas, Bruns, Tony, Danielsen, Karen Vagner, Coenraad, Minneke, Merli, Manuela, Stauber, Rudolf, Zoller, Heinz, Ramos, Jose Presa et al.
DOI: 10.1016/j.jhep.2020.11.019

Endoscopic stenting for gastroduodenal outlet obstruction of a malignant origin, real life experience in a single center.

PMID: 32496109
Journal: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Year: 2020
Reference: Rev Esp Enferm Dig. 2020 Sep;112(9):712-715. doi: 10.17235/reed.2020.6600/2019.
Impact factor: 1.591
Publication type: Paper in international publication
Authors: Armengol Bertroli, Jordi, Pascasio-Hernandez, Mario Jose, Benages Curell, Anna, Castillo Cejas, Maria Dolores, Pigrau Pastor, Marc, Sihuay Diburga, Denisse, Guevara Cubas, Jorge, Castro-Reyes, Luz Maria, Jimenez Hernandez, Cesar, Tasayco Huaman, Stephanie et al.
DOI: 10.17235/reed.2020.6600/2019

Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review.

PMID: 32336663
Journal: Surgery for Obesity and Related Diseases
Year: 2020
Reference: Surg Obes Relat Dis. 2020 Sep;16(9):1361-1369. doi: 10.1016/j.soard.2020.03.013. Epub 2020 Mar 20.
Impact factor: 3.812
Publication type: Paper in international publication
Authors: Talavera-Urquijo, Eider, Beisani, Marc, Balibrea, Jose M, Alverdy, John C et al.
DOI: 10.1016/j.soard.2020.03.013

Immune-related hepatitis related to checkpoint inhibitors: clinical and prognostic factors.

PMID: 32329119
Journal: LIVER INTERNATIONAL
Year: 2020
Reference: Liver Int. 2020 Aug;40(8):1906-1916. doi: 10.1111/liv.14489. Epub 2020 Jun 3.
Impact factor: 5.175
Publication type: Paper in international publication
Authors: Riveiro-Barciela, Mar, Barreira-Diaz, Ana, Vidal-Gonzalez, Judit, Munoz-Couselo, Eva, Martinez-Valle, Fernando, Viladomiu, Lluis, Minguez, Beatriz, Ortiz-Velez, Carolina, Castells, Lluis, Esteban, Rafael et al.
DOI: 10.1111/liv.14489

Transient elastography in direct acting antiviral era. Relation between liver stiffness measurement after sustained virological response and histology.

PMID: 31816146
Journal: JOURNAL OF VIRAL HEPATITIS
Year: 2020
Reference: J Viral Hepat. 2020 Apr;27(4):453-455. doi: 10.1111/jvh.13245. Epub 2019 Dec 18.
Impact factor: 3.561
Publication type: Paper in international publication
Authors: Martinez-Camprecios, Joan, Bonis Puig, Sara, Pons Delgado, Monica, Salcedo Allende, Maria Teresa, Minguez Rosique, Beatriz, Genesca Ferrer, Joan et al.
DOI: 10.1111/jvh.13245

New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors.

PMID: 29239718
Journal: JOURNAL OF GENERAL VIROLOGY
Year: 2018
Reference: J Gen Virol. 2018 Jan;99(1):97-102. doi: 10.1099/jgv.0.000996. Epub 2017 Dec 14.
Impact factor: 2.514
Publication type: Paper in international publication
Authors: Chen, Qian, Riveiro-Barciela, Mar, Buti, Maria, Esteban, Rafael, Esteban, Juan Ignacio, Rodriguez-Frias, Francisco, Quer, Josep, Llorens, Meritxell, Perales, Celia, Soria, Maria Eugenia et al.
DOI: 10.1099/jgv.0.000996

Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing.

PMID: 28988126
Journal: VIRUS RESEARCH
Year: 2018
Reference: Virus Res. 2018 Jan 2;243:52-59. doi: 10.1016/j.virusres.2017.10.003. Epub 2017 Oct 4.
Impact factor: 2.484
Publication type: Paper in international publication
Authors: Sopena, Sara, Godoy, Cristina, Tabernero, David, Homs, Maria, Gregori, Josep, Riveiro-Barciela, Mar, Ruiz, Alicia, Esteban, Rafael, Buti, Maria, Rodriguez-Frias, Francisco et al.
DOI: 10.1016/j.virusres.2017.10.003

Efficacy and safety of daclatasvir-based antiviral therapy in HCV recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multi-centre cohort study.

PMID: 28608619
Journal: TRANSPLANT INTERNATIONAL
Year: 2017
Reference: Transpl Int. 2017 Oct;30(10):1041-1050. doi: 10.1111/tri.12999. Epub 2017 Jul 27.
Impact factor: 3.079
Publication type: Paper in international publication
Authors: Testillano, Milagros, Salcedo, Magdalena, Prieto, Martin, Castells, Lluis, Pascasio, Juan Manuel, Alvarez, Jose Luis Montero, Fernandez, Inmaculada, Sanchez-Antolin, Gloria, Gonzalez-Dieguez, Luisa, Garcia-Gonzalez, Miguel et al.
DOI: 10.1111/tri.12999

Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis.

PMID: 27323654
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2017
Reference: Arch Bronconeumol. 2017 Jan;53(1):13-18. doi: 10.1016/j.arbres.2016.05.003. Epub 2016 Jun 17.
Impact factor: 2.979
Publication type: Paper in national publication
Authors: Blanco, Ignacio, Martinez, Maria Teresa, Rodriguez, Esther, Bustamante, Ana, Casas, Francisco, Cadenas, Sergio, Hernandez, Jose M, Lazaro, Lourdes, Torres, Maria, Curi, Sergio et al.
DOI: 10.1016/j.arbres.2016.05.003

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.

PMID: 28585554
Journal: AMERICAN JOURNAL OF GASTROENTEROLOGY
Year: 2017
Reference: Am J Gastroenterol. 2017 Sep;112(9):1400-1409. doi: 10.1038/ajg.2017.157. Epub 2017 Jun 6.
Impact factor: 9.566
Publication type: Paper in international publication
Authors: Roget, Merce, Lens, Sabela, Fernandez, Inmaculada, Rodriguez-Tajes, Sergio, Hontangas, Vanessa, Vergara, Mercedes, Forne, Montserrat, Calleja, Jose Luis, Diago, Moises, Llaneras, Jordi et al.
DOI: 10.1038/ajg.2017.157

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction.

PMID: 28527664
Journal: JOURNAL OF HEPATOLOGY
Year: 2017
Reference: J Hepatol. 2017 Oct;67(4):669-679. doi: 10.1016/j.jhep.2017.05.010. Epub 2017 May 18.
Impact factor: 12.486
Publication type: Paper in international publication
Authors: Ni, Yi, Hommel, Mirja, Palomo, Laura, Segura, Victor, Olague, Cristina, Vales, Africa, Ruiz-Ripa, Alicia, Buti, Maria, Salido, Eduardo, Prieto, Jesus et al.
DOI: 10.1016/j.jhep.2017.05.010

Blog

News

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Job offers

Research Fellow-Liver Diseases.
Start date:
10/05/2023
End date:
24/05/2023
Document: Download
Postdoctoral researcher-Liver Research Group.
Start date:
05/05/2023
End date:
24/05/2023
Document: Download
Clinical researcher for the Decision Project-The Liver Unit of HUVH and the research group of Liver Diseases of VHIR
Start date:
05/05/2023
End date:
19/05/2023
Document: Download

Estudi sobre els patrons de consum habitual de l'alcohol en població jove

Des de Vall d'Hebron estem buscant 200 persones voluntàries sanes d'entre 18 i 30 anys per a participar en un estudi sobre els patrons de consum habitual de l'alcohol en població jove, en el marc del projecte StopALD.

Més informació